BLACK WEEKSViales −15% · kits −10% · resto −5%con el códigoEnvío gratis en Alemania a partir de 200 €

Esta página se ha traducido automáticamente y puede contener errores. ¿Eres hablante nativo? Nos encantaría recibir tus comentarios y correcciones.Enviar comentarios

The Peptide Desk The Peptide Desk
ARA-290, foto del producto
Healing

ARA-290

Healing

  • Envío desde Alemania

Pedido

Precio unitario - Envío gratis en Alemania a partir de 200 € durante las Black Weeks
  • DHL con seguimiento
  • Embalaje discreto

4.6 de 5 en Trustpilot73 reseñas

De un vistazo

ARA-290 en cifras

Las cifras clave de nuestra enciclopedia.

Entrada completa de la enciclopedia
Class
EPO-derived peptidenon-hematopoietic
Half-life
short
Use
Subcutaneousin mg
Sizes
10 to 16 mg2 sizes in the shop

Todavía no hay ningún análisis de laboratorio de ARA-290. Vota por élHazlo analizar tú mismo, pagamos la mitadTodos los análisis de laboratorio

Conocimiento

Todo sobre ARA-290

Conviene tenerlo

Lo que necesitas con ello

El agua bacteriostática se añade automáticamente a tu carrito. Jeringas y toallitas con un clic.

Jeringas de insulina

10 uds. · 5.50 €

Toallitas con alcohol

50 uds. · 10 €

¿Cuánta agua?

Unidades en la jeringa para tu tamaño de vial.

Abrir calculadora →

FAQ

Preguntas frecuentes

Fuentes de cada respuesta: entrada de la enciclopedia

¿Aún tienes alguna pregunta?

Escríbenos, nuestro equipo te ayudará.

What is ARA-290?

A small peptide with the drug name cibinetide, designed from the structure of erythropoietin. Unlike EPO it is meant not to make the body form red blood cells. It acts through the innate repair receptor, a complex of the EPO receptor and CD131.

What do the sarcoidosis studies show?

In the first pilot study with 22 participants the symptom score fell by 11.5 points after 4 weeks versus 2.9 with placebo. A second study with daily dosing under the skin for 28 days found fewer symptoms, more nerve fibres in the cornea and a longer walking distance. In the phase 2b trial with 64 participants only the middle study dose was significant.

What about type 2 diabetes?

In a phase 2 trial with daily dosing under the skin for 28 days long-term blood sugar and blood lipids improved over 56 days and so did nerve pain symptoms. In participants with clearly reduced corneal nerve fibre density this density increased, with placebo it did not.

Does ARA-290 help with eye diseases?

In diabetic macular oedema a small study with 9 participants showed no improvement in visual acuity or retinal thickness after 12 weeks. Only the visual function questionnaire came out slightly better. The trial ended early because the study drug expired.

Does ARA-290 affect mood?

In a study with 36 healthy people the brain responded more weakly to happy faces one week after dosing and attention to positive pictures increased. ARA-290 had no effect on mood or emotional state. A clear antidepressant-like profile did not emerge.

Which side effects are known?

No safety concerns appeared in the studies. In diabetic macular oedema there were no serious side effects and no antibodies against the compound after 12 weeks. The abstracts give no percentages for individual side effects.

Relacionados

Productos relacionados